Detection of HPV 16 and HPV 18 DNA in the blood of patients with cervical cancer
- PMID: 15648077
- DOI: 10.1002/jmv.20294
Detection of HPV 16 and HPV 18 DNA in the blood of patients with cervical cancer
Abstract
Persistent infection of the uterine cervix with high-risk human papillomaviruses (HPV) is causally associated with cancer of the cervix. A few studies have reported the presence of HPV DNA in the blood of women with cervical neoplasia. The aim of this study was to determine if HPV DNA could be detected in whole blood of women with a range of cervical pathologies and with HPV 16 or 18 cervical infections and if there is a correlation between cervical lesion grade and the appearance of HPV DNA in the circulatory system. Forty-five women with histologically graded cervical cancer were confirmed to have cervical HPV 16 or 18 infections. Eleven (24.4%) of these women had detectable HPV 16 or 18 in their blood. The HPV types detected in the blood matched those detected at the cervix. No HPV 16 or 18 DNA was detected in the blood of 32 women with pre-cursor cervical lesions or normal cervical pathology but who had cervical HPV 16 or 18 infections. One of 77 women with normal cervical pathology and no cervical HPV infection was positive for HPV 16 DNA in her blood. The results indicate that HPV DNA can be detected in the blood of women with more advanced cervical carcinomas but not in the blood of women with pre-cursor cervical lesions. The results of our study indicate that the role of HPV DNA in the circulatory system appears not be of diagnostic significance and HPV DNA is only detectable in women with more advanced cervical cancers.
2005 Wiley-Liss, Inc.
Similar articles
-
[Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].Mikrobiyol Bul. 2008 Apr;42(2):273-82. Mikrobiyol Bul. 2008. PMID: 18697425 Turkish.
-
Human papillomavirus DNA in urine samples of women with or without cervical cancer and their male partners compared with simultaneously collected cervical/penile smear or biopsy specimens.J Clin Virol. 2006 Nov;37(3):190-4. doi: 10.1016/j.jcv.2006.07.007. Epub 2006 Aug 22. J Clin Virol. 2006. PMID: 16931139
-
HPV detection in cervical cancer patients in northern Poland.Oncol Rep. 2002 Jul-Aug;9(4):871-4. Oncol Rep. 2002. PMID: 12066224
-
HPV types in women with normal cervical cytology.IARC Sci Publ. 1992;(119):75-84. IARC Sci Publ. 1992. PMID: 1330919 Review.
-
[HPV infection of the cervix and capabilities of advanced diagnostics].Akush Ginekol (Sofiia). 2010;49(3):40-3. Akush Ginekol (Sofiia). 2010. PMID: 20734655 Review. Bulgarian.
Cited by
-
Differential microRNA Expression Analysis in Patients with HPV-Infected Ovarian Neoplasms.Int J Mol Sci. 2024 Jan 7;25(2):762. doi: 10.3390/ijms25020762. Int J Mol Sci. 2024. PMID: 38255835 Free PMC article.
-
Clinical applications and utility of ctDNA in cervical cancer and its precursor lesions: from screening to predictive biomarker.Cancer Cell Int. 2023 Dec 18;23(1):329. doi: 10.1186/s12935-023-03132-0. Cancer Cell Int. 2023. PMID: 38110977 Free PMC article. Review.
-
Photoelectrochemical biosensor based on SiW12@CdS quantum dots for the highly sensitive detection of HPV 16 DNA.Front Bioeng Biotechnol. 2023 Jun 14;11:1193052. doi: 10.3389/fbioe.2023.1193052. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 37388766 Free PMC article.
-
Molecular evaluation of human papillomavirus as an oncogenic biomarker in prostate cancer.Mol Biol Rep. 2023 Jul;50(7):5719-5724. doi: 10.1007/s11033-023-08474-6. Epub 2023 May 22. Mol Biol Rep. 2023. PMID: 37217619
-
The Diagnostic Value of Circulating Cell-Free HPV DNA in Plasma from Cervical Cancer Patients.Cells. 2022 Jul 11;11(14):2170. doi: 10.3390/cells11142170. Cells. 2022. PMID: 35883612 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical